Kun‐Yuan Chiu

Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Thomas Powles, Piotr Tomczak, Se Hoon Park et al. · The Lancet Oncology · 2022 · 262 citations · Full text

Pembrolizumab Plus Olaparib for Patients With Previously Treated and Biomarker-Unselected Metastatic Castration-Resistant Prostate Cancer: The Randomized, Open-Label, Phase III KEYLYNK-010 Trial

Emmanuel S. Antonarakis, Se Hoon Park, Jeffrey C. Goh et al. · Journal of Clinical Oncology · 2023 · 121 citations · Full text

Retzius-sparing Robotic-assisted Radical Prostatectomy Associated with Less Bladder Neck Descent and Better Early Continence Outcome

Li‐Wen Chang, Sheng-Chun Hung, Ju‐Chuan Hu et al. · Anticancer Research · 2018 · 73 citations · Full text

Inhibition of growth, migration and invasion of human bladder cancer cells by antrocin, a sesquiterpene lactone isolated from Antrodia cinnamomea, and its molecular mechanisms

Kun‐Yuan Chiu, Chun‐Chi Wu, Chi-Hao Chia et al. · Cancer Letters · 2015 · 57 citations

Chemoprevention Strategy, Medicine, Antrodia Cinnamomea +6

Nortriptyline induces mitochondria and death receptor-mediated apoptosis in bladder cancer cells and inhibits bladder tumor growth in vivo

Sheau-Yun Yuan, Chen‐Li Cheng, Hao‐Chung Ho et al. · European Journal of Pharmacology · 2015 · 39 citations

Urology, Oncology, Genitourinary Cancer +8